An atypical presentation of small bowel obstruction and perforation secondary to sporadic synchronous intra-abdominal desmoid tumours  by Abdalla, Sala et al.
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INTRODUCTION:  Desmoid  tumours  (DTs)  are rare, soft tissue  tumours  which  account  for  0.03%  of  all  neo-
plasms. They  are  characteristically  locally  invasive  but  do  not  metastasize.  There  is frequent  association
with females  of  reproductive  age,  a history  of  abdominal  surgery  or trauma  and a  family  history  of  ﬁbro-
matoses.  Intra-abdominal  DTs are  infrequently  sporadic  and  more  commonly  associated  with  inherited
disorders  such  as  familial  adenomatous  polyposis  (FAP),  attenuated  FAP  and  Gardener’s  syndrome.
PRESENTATION  OF  CASE:  The  authors  report  a rare  case  of small  bowel  obstruction  and  perforation  sec-
ondary to sporadic,  synchronous  intra-abdominal  DTs  in  a 54-year  old  man  with  atypical  symptoms  and
no risk  factors  or family  history.
DISCUSSION:  Intra-abdominal  DTs have  a  worse  prognosis  as  they  can  cause  intestinal  bleeding,  obstruc-
tion  and  perforation.  Due to the rarity  of  these  tumours  there  are  no clear  guidelines  on  their management
and  this  is  instead  based  on small  case  series  from  specialist  centres.  In the  non-acute  setting  patients
with  sporadic  intra-abdominal  DTs  should  be managed  in  a specialist  sarcoma  unit by a multidisciplinary
team.  In the  presence  of  FAP  or  other  polyposis  syndromes  patients  with  DTs  should  be managed  at a
specialist  colorectal  unit.  Emergent  presentations  require  emergency  surgery  in  suitable  candidates.
CONCLUSION:  In  non-emergency  presentations  of DTs,  it is  essential  to  exclude  FAP,  AFAP  and  other
hereditary  polyposis  syndromes  since  this  affects  treatment  and  subsequent  follow-up.
©  2016  The  Authors.  Published  by Elsevier  Ltd.  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
he  CCaccess  article  under  t
. Introduction
Desmoid tumours (DTs), also known as ﬁbromatoses, are rare
oft tissue tumours that result from the abnormal proliferation
f ﬁbroblasts in musculo-aponeurotic structures. They account for
.03% of all neoplasms and can occur in mesenchymal structures of
he limb and limb girdle, intra-abdominally or within the abdomi-
al wall [1,2]. Although they are thought to lack metastatic capacity,
Ts can cause signiﬁcant morbidity and even mortality due to
ize, compression and invasion of adjacent structures. Aetiological
actors associated with DTs are female gender especially of repro-
uctive age, a history of abdominal surgery or trauma, and a family
istory of ﬁbromatoses [3]. Intra-abdominal DTs are more com-
only associated with familial adenomatous polyposis (FAP), an
utosomal dominant inherited disorder that arises from mutations
f the APC tumour suppressor gene [4]. However, in approxi-
ately 5% of cases they can occur sporadically. An association with
ardener’s syndrome and attenuated FAP has also been well docu-
ented. Desmoid tumours localized in the abdomen have a worse
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prognosis as they can cause intestinal bleeding, obstruction and
perforation. Retroperitoneal involvement can lead to compression
of major blood vessels and ureteral obstruction. We report a rare
case of a patient presenting in an acute confusional state who was
found to have small bowel obstruction and perforation due to two
large intra-abdominal DTs arising from the small bowel mesentery.
2. Presentation of case
A 54-year old Nigerian man  presented to the emergency depart-
ment in an acute confusional state. He had a background of
three weeks of colicky abdominal pain which was associated with
intermittent vomiting, hiccupping and polydipsia. He had been
opening his bowels daily and there was no history of weight-loss,
haematemesis or rectal bleeding. He was  scheduled to have an
abdominal ultrasound scan and on the day prior to presenting to
hospital he had an oesophago-gastro-duodenoscopy (OGD). This
showed gastritis and a gastric ulcer in gastric antrum and pre-
pyloric region, respectively, as well as a large volume of gastric
content despite a 10-h fast. A tissue biopsy was  taken. He had a
history of hypertension and no relevant surgical or family history.
Clinically he was acutely confused, dehydrated and pyrexial. Chest
examination was  unremarkable and there were no focal neurolog-
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Sections from computed tomography scan with oral and intravenous contrast enhancement demonstrating the locations of the two intra-abdominal desmoid tumours
indicated by the arrows. Arrows “A” demonstrate the distal jejunal lesion and arrows “B” show the lesion in the ileocaecal region.
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sig. 2. 7 × 8 × 4 cm tumour arising from distal jejunal mesentery, involving the bow
nd  haemorrhage in the mesentery.
cal signs. His abdomen was mildy distended and tender with no
igns of peritonism or palpable masses. Bowel sounds were scanty
nd rectal examination was unremarkable.
Laboratory tests revealed a mild normocytic anaemia
Haemoglobin count 11.5 g/dL), raised inﬂammatory markers
White Cell Count 29.5 10*9/L, C—reactive protein 238 mg/L),
mpaired renal function (Urea 23.4 mmol/L, Creatinine 233,
stimate GFR 25 mL/min/1.73), a signiﬁcant hyponatraemia (Na
04 mmol/L) and a raised serum lactate (3.4 mmol/L). Serum osmo-
ality, urinary Sodium and urinary osmolality were all decreased
244 mosmol/kg, 27 mmol/L and 206 mosmol/Kg, respectively).
An erect chest radiograph was unremarkable with no evidence
f pneumoperitoneum. Computed tomography (CT) scanning of the
ead was unremarkable. However, a CT of the abdomen and pelvis
evealed two soft tissue masses in the abdomen; the largest mea-
uring 6.8 cm in the mid  abdomen appeared to be causing proximal
mall bowel obstruction, and separate mass of similar tissue den-
ity measuring 5 cm adjacent to the ileocaecal region surrounded
y a small amount of free ﬂuid (Fig. 1). He was admitted into the
ntensive care unit for support and monitoring.
At laparotomy the next day he was found to have a necrotic 7 cm
ass arising from the mesentery of the distal jejunum/proximal
leum invading the contiguous small bowel, causing obstruction
nd perforation (Fig. 2). A second mass measuring 6 cm was found
rising from the mesoappendix and inﬁltrating into the ileocae-
al region (Fig. 3). This was causing obstruction of the terminal
leum. Ileal and ileocaecal resections were carried out but due
o the poor general condition of the patient four blind ending
oops were left in the abdomen. A planned re-look laparotomy
as undertaken 48 h later with formation of jejuno-ileal and ileo-
olic anastomosis. Five days later he had a third laparotomy for
uspected anastomotic dehiscence and was found to have a defectl. The bowel wall is covered in ﬁbrinous exudates and there is associated congestion
in the jejuno-ileal anastomosis. A controlled enterostomy using a
Foley catheter was  formed, and the abdomen was  managed as a
laparostomy for 10 days after which an abdominal VAC dressing
was applied to facilitate abdominal wall closure
Microscopically, both lesions involved the walls of each bowel
segment and formed a mesenteric mass, involving the serosal
surface, which was  coated in acute inﬂammatory exudates. The
lesions were formed of bland, uniform spindle cells and partially
replaced muscularis propria. The spindle cells had a ﬁbroblas-
tic/myoﬁbroblastic appearance. The ileocaecal mass displayed
prominent keloid collagen (Fig. 4).
Immunohistochemical markers were performed. The lesional
spindle cells in each mass expressed smooth muscle actin, Beta-
catenin and Vimentin. Other immunomarkers were negative
(ALK-1, Bcl-2, CD117, CD34, CD45, Desmin, EMA, MNF116, p63 and
S100). A diagnosis of Desmoid type ﬁbromatoses/synchronous DTs
was made and conﬁrmed by an external expert sarcoma hitopathol-
ogist. The immunohistochemical proﬁle excluded differential
diagnoses of gastrointestinal stromal tumour (GIST), inﬂamma-
tory myoﬁbroblastic tumour, leiomyoma, peripheral nerve sheath
tumour, spindle cell carcinoma, peripheral nerve tumour and
metastatic spindle cell melanoma.
The patient’s post-operative recovery was slow with a 49-day
stay in the intensive care unit and multiple theatre sessions for
change of abdominal VAC dressing. He was an inpatient for a
total of 57 days and was eventually discharged with an abdomi-
nal VAC dressing, with planned community follow-up. He was seen
in outpatients 6 weeks following discharge and was referred for a
colonoscopy which did not show any evidence of colonic polyposis.
As there was no family history of or clinical evidence for FAP he was
referred to a specialist sarcoma centre for follow up.
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Fig. 3. 6 cm desmoid tumour arising from the meso-appendix.
Fig. 4. (A) Ileal mass. Acute inﬂammatory exudate at serosal surface (left). (H&E medium power). (B) Ileal mass replacing the bowel wall (H&E scanning view). (C) Ileal
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mass.  Fibromatosis, characterised by uniform spindle cells, red cell extravasation a
ollagen.  (H&E medium power). (E) Ileal mass. Expression of smooth muscle actin (
 characteristic ﬁnding in ﬁbromatosis.
. Discussion
Only 5% of sporadic DTs are intra-abdominal. In contrast, 80%
f patients with familial adenomatous polyposis (FAP)-associated
esmoid tumours develop intra-abdominal disease. The majority
f intra-abdominal DTs (85%) arise from the mesentery [5,6] and
an cause signiﬁcant morbidity and mortality due to their locally
nﬁltrative behaviour which can result in bowel obstruction, perfo-
ation or ﬁstula formation. The subject of this case report presented
o the physicians in an acute confusional state with a history of poly-
ipsia and ﬁnding of profound hyponatraemia (Na 104 mmol/L).
owel obstruction was not initially considered in the differen-
ial diagnoses. The collateral history then revealed three weeks
f abdominal pain and intermittent vomiting but there was no
eport of constipation. The patient had no prior history of surgery
r trauma to the abdomen, and no family history of ﬁbromatoses
r FAP. The ﬁnal diagnosis of bowel obstruction was not estab-
ished until a CT scan of the abdomen and pelvis revealed the two
ntra-abdominal masses which were thought to represent GIST or
ymphoma. The diagnosis of desmoid tumours was never consid-
red. His demographics and lack of risk factors and/or family history
ade this diagnosis all the more unlikely. The ﬁnal diagnosis wascasional mitoses. (H&E high power). (D) Ileo-caecal mass with prominent keloidal
al control = muscularis propria). (F) Ileal mass. Nuclear expression of Beta-catenin,
established after histological analysis of the specimens and fur-
ther conﬁrmation by an external expert sarcoma hitopathologist.
The overall presentation was  atypical for bowel obstruction and
perforation from synchronous, mesenteric DTs.
The conﬁrmation of the non-FAP status of the disease was
made after the patient, who  was  in his mid-ﬁfties, had a follow-
up colonoscopy which revealed no colonic polyposis. It is essential
to exclude FAP and investigate for attenuated FAP (AFAP) in all
patients presenting with abdominal DTs since these two conditions
carry a very high risk of development of colorectal cancer [7–11].
The diagnosis of FAP requires the presence of more than 100 colonic
adenomas. Attenuated AFP (AFAP), where the mutation occurs at
the extreme ends of the APC gene, is deﬁned by the presence of
three and 99 adenomas.
Histological assessment is mandatory for differentiating DTs
from other neoplasms such as gastrointestinal stromal tumours,
lymphoma, pleomorphic sarcoma and ﬁbrosarcoma. Microscopi-
cally they are composed of spindle- or stellate-shaped ﬁbroblastic
cells embedded in a collagenous stroma. Genetic testing for FAP
or AFAP was not performed as up to 30% of patients with a clear
FAP phenotype and 75% with AFAP have no identiﬁable APC gene
mutation [12].
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Ultrasonography (USS), computed tomography (CT) and mag-
etic resonance imaging (MRI) can and have all been used to
stablish the nature, extension and anatomical relationship of DTs.
n USS DTs appear as lesions of variable echogenicity and on CT
canning they are homogenously enhanced with well-deﬁned mar-
ins. Desmoid tumours appear hypo-intense on T1-weighted MRI
nd predominantly hyper-intense on T2-weighted MRI, reﬂecting
he proliferation of ﬁbroblasts [13,14].
Due to the rarity of these tumours there are no clear guidelines
n their management and this is instead based on small case series
rom specialist centres [12,15]. Before consideration of surgery, in
he non-acute setting, patients should be fully investigated for FAP,
FAP and other hereditary polyposis syndromes with a family his-
ory, full colonoscopy with dye spray (chromoendoscopy), random
iopsies to identify microadenomas, and OGD to look for cystic
land polyps in the stomach and duodenal adenomas.
The management of desmoid tumours is then dependent on
hether they are sporadic or not. In the presence of FAP or other
olyposis syndrome the patient should be managed at a special-
st colorectal unit. In these patients surgery is associated with
igh recurrence rates and is therefore only used when absolutely
ecessary. Instead medical therapies such as non-steroidal anti-
nﬂammatory drugs, Tamoxifen and chemotherapy are trialled as
rst and often second line therapy.
This contrasts with the management of sporadic intra-
bdominal DTs, which should be managed in a specialist sarcoma
nit by a multidisciplinary team. They are thought to have low
ecurrence rates after resection and therefore surgery is recom-
ended as the ﬁrst-line treatment for amenable tumours.
Emergent presentations such as in this case require emergency
aparotomy in suitable surgical candidates.
In our patient, the treatment of choice was small bowel and
leocaecal resections as resection of the mesenteric tumours alone
ould have interrupted the mesenteric blood supply to the bowel,
esulting in bowel ischaemia. The signiﬁcance of margins is con-
roversial. Some studies suggest that margins are signiﬁcant for
redicting recurrence but others have demonstrated that they do
ot add prognostic value [16,17].
. Conclusion
This is a rare case of sporadic, synchronous intra-abdominal
Ts presenting with atypical symptoms. Sporadic DTs infrequently
resent with intra-abdominal manifestations. The patient made good recovery following emergency surgery. In non-emergency
ettings it is essential to exclude FAP, AFAP and other hereditary
olyposis syndromes since this affects treatment and subsequent
ollow-up.
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